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Time to strengthen HIV treatment and prevention for youth
In The Lancet HIV, Mhairi Maskew and colleagues1 use 
data from a large national laboratory database in South 
Africa to examine trends in access to public sector HIV 
treatment programmes by children and adolescents 
aged 1–19 years between 2005 and 2016. The authors 
should be congratulated for highlighting important 
findings using national data in this often underexamined 
population, information that is needed to mount 
a national response. The authors report a ten times 
increase in the number of adolescents with viral load 
data, suggestive of antiretroviral therapy (ART) use, 
between 2005–08 and 2013–16. Prevention of mother-
to-child transmission has worked remarkably well, with 
patients starting ART steadily decreasing since 2011 
among patients aged 1–14 years.1 However, in line with 
global trends, the authors also identified l arge g aps 
in ART initiation among adolescents with presumed 
horizontal infection; less than half of patients seeking 
care aged 15–19 years started ART.1 
South Africa is the country with the largest 
number of people living with HIV in the world.2 The 
increase in adolescents who started treatment 
since 2008 is a testament to the scale-up of the 
HIV treatment programme. In September, 2016, 
the South African Government began to 
implement “test and start”, making ART available 
to anyone with HIV. Despite substantial changes in 
treatment guidelines, barriers to HIV care and 
treatment still hinder adolescents living with HIV. In 
2015, HIV was the second leading natural cause of death 
among people aged 15–24 years in South Africa,3 with 
HIV-related deaths rising among adolescents.4 In sub-
Saharan Africa, testing uptake among adolescents is 
alarmingly low.5  In 2016, only 49% of adolescents 
aged 15–19 years reported ever being tested for 
HIV.6 Adolescents cite many barriers to testing, 
including low perception of infection risk, not having 
been offered a 
test, fear of stigmatisation, fear of knowing their status, 
and fear of breach of confidentiality of test results.5,7 
Furthermore, adolescents who identify as members of 
key populations for HIV susceptibility are far less likely to 
access testing and care services.7
While HIV testing is a major gap in the HIV care 
cascade, linkage to care for HIV-infected adolescents 
also falls far short of the 90% target set by UNAIDS, 
as highlighted by Maskew and colleagues.1 While the 
analysis in this paper estimates that less than half of 
adolescents aged 15–19 years in care started ART,1 a 
meta-analysis of adolescent studies in South Africa 
estimated that only 14% of HIV-positive adolescents 
are on ART and just 10% are virally suppressed.2 Among 
HIV-positive adolescents around the world, barriers 
that contribute to poor linkage to and retention in 
care include concerns about stigma, perceived lack 
of confidentiality at clinics, lack of knowledge and 
experience with health services, poor treatment by 
health-care providers, denial about HIV diagnoses, and 
lack of adolescent-friendly services.8,9 
The research presented by Maskew and colleagues1 
starts with adolescents who have engaged with the HIV 
care system in South Africa. Given gaps in testing and 
linkage to care, the number of HIV-positive adolescents 
not in care reported here is likely an underestimate. 
Nevertheless, the point of this study is clear, adolescents 
are being left behind by treatment programmes 
in significant numbers. With an expanding global 
adolescent population, the high HIV incidence among 
adolescents, and the gap in HIV treatment services, the 
findings here emphasise the need to not only strengthen 
care programmes but to also prevent new HIV infections 
if programmes are to care for all people living with HIV. 
Few evidence-based interventions exist to improve 
linkage to and retention in care for adolescents, and even 
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fewer have been taken to scale; this must change if we 
want to see reductions in new infections and alter the 
course of the HIV epidemic.10 To address the adolescent 
epidemic, we must understand the problem. Maskew 
and colleagues1 take an important step in highlighting 
that the battle against HIV is far from over and that 
government, donors, programmes, and researchers 
must act with urgency to develop, test, and implement 
evidence-based interventions to prevent new infections 
and improve access to and maintenance of care for 
adolescents. 
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